Newell Brands (NWL) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 85.71%. A quarter ago, it was expected that this consumer products company would post earnings of $0.14 per share when it actually produced earnings of $0.16, delivering a surprise of 14.29%.Over the last four quarters, ...

Group 1 - Bausch + Lomb reported a quarterly loss of $0.07 per share, missing the Zacks Consensus Estimate of $0.03, and compared to earnings of $0.07 per share a year ago, representing an earnings surprise of -333.33% [1] - The company posted revenues of $1.14 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 0.86%, and this is an increase from year-ago revenues of $1.1 billion [2] - Bausch + Lomb shares have declined approximately 24% since the beginning of the year, while the S&P 500 has decreased by 5.5% [3] Group 2 - The earnings outlook for Bausch + Lomb is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend for estimate revisions for Bausch + Lomb is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is $0.16 on revenues of $1.27 billion, and for the current fiscal year, it is $0.67 on revenues of $5 billion [7] Group 3 - The Medical Services industry, to which Bausch + Lomb belongs, is currently ranked in the top 29% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8]

Company Performance - OneSpaWorld (OSW) reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.21 per share, and up from $0.19 per share a year ago, representing an earnings surprise of 4.76% [1] - The company posted revenues of $219.63 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.18%, and compared to revenues of $211.23 million in the same quarter last year [2] - Over the last four quarters, OneSpaWorld has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Outlook - OneSpaWorld shares have declined approximately 11.4% since the beginning of the year, while the S&P 500 has decreased by 5.5% [3] - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $236.44 million, and for the current fiscal year, it is $0.94 on revenues of $952.15 million [7] Industry Context - The Leisure and Recreation Services industry, to which OneSpaWorld belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact OneSpaWorld's stock performance [5]

Core Viewpoint - CGI Group reported quarterly earnings of $1.48 per share, slightly missing the Zacks Consensus Estimate of $1.50 per share, but showing an increase from $1.46 per share a year ago [1][2] Financial Performance - The company posted revenues of $2.8 billion for the quarter ended March 2025, which was below the Zacks Consensus Estimate by 0.43%, but an increase from $2.77 billion year-over-year [3] - CGI has surpassed consensus revenue estimates three times over the last four quarters [3] Earnings Surprise and Trends - The earnings surprise for this quarter was -1.33%, while the previous quarter saw a positive surprise of 1.44% [2] - Over the last four quarters, CGI has exceeded consensus EPS estimates two times [2] Stock Performance and Outlook - CGI shares have declined approximately 2.1% since the beginning of the year, compared to a decline of 5.5% for the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is $1.47 on revenues of $2.76 billion, and for the current fiscal year, it is $5.91 on revenues of $11.03 billion [8] Industry Context - The Computer - Services industry, to which CGI belongs, is currently ranked in the top 29% of over 250 Zacks industries, indicating a favorable outlook [9] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact CGI's stock performance [6][9]

Financial Performance - United Therapeutics reported quarterly earnings of $6.63 per share, exceeding the Zacks Consensus Estimate of $6.29 per share, and up from $6.17 per share a year ago, representing an earnings surprise of 5.41% [1] - The company posted revenues of $794.4 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 9.39%, compared to year-ago revenues of $677.7 million [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $6.75 on revenues of $771.36 million, and for the current fiscal year, it is $27.03 on revenues of $3.13 billion [7] - The estimate revisions trend for United Therapeutics is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Drugs industry, to which United Therapeutics belongs, is currently in the top 20% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.90 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.99%. A quarter ago, it was expected that this medical technology company would post earnings of $1.26 per share when it actually produced earnings of $1.45, delivering a surprise of 15.08%.Over the la ...

Core Viewpoint - Trane Technologies reported quarterly earnings of $2.45 per share, exceeding the Zacks Consensus Estimate of $2.20 per share, and showing an increase from $1.94 per share a year ago, indicating strong performance in the current quarter [1] Financial Performance - The company achieved revenues of $4.69 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.13% and up from $4.22 billion year-over-year [2] - Over the last four quarters, Trane Technologies has consistently exceeded consensus EPS estimates [2] Stock Performance and Outlook - Trane Technologies shares have declined approximately 4.3% since the beginning of the year, while the S&P 500 has decreased by 5.5%, indicating relative outperformance [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the sustainability of the recent earnings surprise [3][4] Earnings Estimates - Current consensus EPS estimate for the upcoming quarter is $3.73 on revenues of $5.68 billion, and for the current fiscal year, it is $12.66 on revenues of $21.15 billion [7] - The estimate revisions trend for Trane Technologies is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market [6] Industry Context - The Building Products - Air Conditioner and Heating industry, to which Trane Technologies belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable industry outlook [8]

分组1 - Humana reported quarterly earnings of $11.58 per share, exceeding the Zacks Consensus Estimate of $9.98 per share, and showing an increase from $7.23 per share a year ago, resulting in an earnings surprise of 16.03% [1] - The company posted revenues of $32.11 billion for the quarter ended March 2025, which was 0.33% below the Zacks Consensus Estimate, but an increase from $29.33 billion year-over-year [2] - Humana has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has increased by approximately 2.2% since the beginning of the year, contrasting with the S&P 500's decline of 5.5% [3] - The current consensus EPS estimate for the upcoming quarter is $5.84 on revenues of $31.77 billion, and for the current fiscal year, it is $16.36 on revenues of $126.55 billion [7] - The Medical - HMOs industry, to which Humana belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Group 1: Earnings Performance - Tetra Technologies reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of $0.08 per share, and up from $0.05 per share a year ago, representing an earnings surprise of 37.50% [1] - The company posted revenues of $157.14 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.84%, compared to year-ago revenues of $150.97 million [2] Group 2: Stock Performance and Outlook - Tetra Technologies shares have declined approximately 24.3% since the beginning of the year, while the S&P 500 has decreased by 6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.13 on revenues of $172.08 million, and for the current fiscal year, it is $0.26 on revenues of $619.17 million [7] Group 3: Industry Context - The Oil and Gas - Field Services industry, to which Tetra Technologies belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Insights - WesBanco (WSBC) reported quarterly earnings of $0.66 per share, exceeding the Zacks Consensus Estimate of $0.60 per share, and up from $0.56 per share a year ago, representing a 10% earnings surprise [1] - The company posted revenues of $194.39 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.97%, and up from $145.81 million year-over-year [2] - WesBanco has outperformed consensus EPS estimates three times in the last four quarters and has also topped revenue estimates three times during the same period [2] Earnings Outlook - The sustainability of WesBanco's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.86 on revenues of $255.39 million, and for the current fiscal year, it is $3.30 on revenues of $969.77 million [7] Industry Context - The Banks - Southeast industry, to which WesBanco belongs, is currently ranked in the top 15% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]